Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Diesel Exhaust and Vascular Function

for
Cardiovascular Effects
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 49

Code: NCT01508637

Recruiting

Airway Remodeling and Rhinovirus in Asthmatics

for
Asthma, Respiratory Disease
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 65

Code: NCT05775952

Recruiting

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

for
Lung Diseases
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18 - 70+

Code: NCT06494033

Recruiting

Maintaining Exercise After Cardiac Rehabilitation

for
Cardiovascular Disease
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 40+

Code: NCT00230724

Phase 3, Recruiting

Heat Therapy and Omega 3 on Cardio-Metabolic Health

for
Hypertension
Location: Lubbock TX
Sponsor: Texas Tech University

Sex: All

Age: 18 - 65

Code: NCT04051034

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

(Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups

for
Insulin Resistance, Type 2 Diabetes Mellitus,
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18 - 50

Code: NCT00249314

Recruiting

DeBakey Cardiovascular Magnetic Resonance Study

for
Cardiovascular Diseases
Location: Houston TX
Sponsor: Dipan Shah

Sex: All

Age: 0+

Code: NCT04281823

Recruiting

Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease

for
Chronic Lung Disease, Bronchopulmonary Dysplasia
Location: Morgantown WV
Sponsor: West Virginia University Healthcare

Sex: All

Age: 0+

Code: NCT01721655

Phase 2, Phase 3, Recruiting

BLOOM: Biological Legacy of Origin in Mother-Infant Dyads

for
Chronic Kidney Diseases, Cardiovascular Diseases
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 0 - 10

Code: NCT02000895

Recruiting

Cardiology Biobank Registry

for
Cardiovascular Disease
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 20+

Code: NCT00378924

Recruiting

Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension

for
Hypertension
Location: Detroit MI
Sponsor: Wayne State University

Sex: All

Age: 30 - 70+

Code: NCT01472796

Recruiting

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

for
Anxiety, Wellness, Psychological, Overweight or Obesity,
Location: Miami FL
Sponsor: Duke University

Sex: All

Age: 12 - 17

Code: NCT06596265

Recruiting

The Effect of Acupuncture on Blood Pressure and Heart Rate Variability (HRV)

for
Hypertension
Location: Chesterfield MO
Sponsor: Logan College of Chiropractic

Sex: All

Age: 20 - 65

Code: NCT00724763

Phase 1, Phase 2, Recruiting

Tailored Videos to Reduce Tobacco Smoke Exposure Among Pregnant Women and Newborns

for
Cardiovascular Diseases, Heart Diseases
Location: Providence RI
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: Female

Age: 16+

Code: NCT00142623

Recruiting

Polypill for Prevention of Cardiomyopathy

for
Type 2 Diabetes, High Blood Pressure
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06143566

Phase 1, Phase 2, Recruiting

Acupuncture and Laser Acupoint Treatment on Hypertension

for
Hypertension
Location: Chesterfield MO
Sponsor: Logan College of Chiropractic

Sex: All

Age: 18 - 70

Code: NCT00459680

Phase 1, Recruiting

UNC Pleural Fluid Registry

for
Lung Cancer, Lung Infection, Breast Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05620329

Recruiting

Evaluation of Body Composition Improvement With Visceral Adiposity-Focused Anti-Obesity Telehealth Program

for
Obesity, Cardiovascular Diseases, Metabolic Syndrome,
Location: Little Rock AR, Cheyenne WY
Sponsor: 20Lighter

Sex: All

Age: 18 - 70+

Code: NCT05219240

Recruiting

Trikafta Exercise Study in Cystic Fibrosis

for
Cystic Fibrosis, Lung Diseases
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19+

Code: NCT05279040

Recruiting

Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension

for
Hypertension
Location: Detroit MI
Sponsor: CardioDynamics

Sex: All

Age: 18+

Code: NCT00913094

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial